ClinicalTrials.gov
ClinicalTrials.gov Menu

A Multicenter, Randomized, Double-blind, Placebo-controlled Phase 3 Study to Evaluate the Safety and Efficacy of ES135 in Subjects With Spinal Cord Injury

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT03229031
Recruitment Status : Recruiting
First Posted : July 25, 2017
Last Update Posted : July 25, 2018
Sponsor:
Information provided by (Responsible Party):
Eusol Biotech Co., Ltd.

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Recruiting
  Estimated Primary Completion Date : December 31, 2022
  Estimated Study Completion Date : December 31, 2024